Chris Murphy actually said...

"I think I share some of the sentiments that Senator Cardin has expressed regarding what is a hard-fought and hard-won compromise, but a compromise first, second, and third."

"This increased cost is born by our healthcare system as a whole, but more specifically by patients as more and more insurance companies place higher cost sharing burdens on biologics."

"We talked about the certainty that the industry needs to start populating the field with more biosimilars."

"Thank you, Mr. Chairman."